Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 11 Mar 2025

AI-enhanced profiling of phage-display-identified anti-TIM3 and anti-TIGIT novel antibodies

in Cancer Immunity and Immunotherapy

Astrid Musnier
Yannick Corde
Adrien Verdier
Mélanie Cortes
Jean-René Pallandre
Christophe Dumet
Adeline Bouard
AbdelRaouf Keskes
Zakaria Omahdi
Vincent Puard

Frontiers in Immunology

doi 10.3389/fimmu.2025.1499810

1,982 views

Review

Published on 10 Mar 2025

The multifaceted role of phosphodiesterase 4 in tumor: from tumorigenesis to immunotherapy

in Cancer Immunity and Immunotherapy

Huili-li Ren
Shao-hui Zhang
Pei-yuan Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1528932

1,092 views

Original Research

Published on 10 Mar 2025

Effect of metachronous primary and secondary solid cancers in patients with multiple myeloma: a retrospective study from a single-center

in Cancer Immunity and Immunotherapy

Yunfei Ji
Hujun Li
Huanxin Zhang
Hai Cheng
Ying Wang
Kailin Xu
Zhenyu Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1516471

904 views

Original Research

Published on 10 Mar 2025

Huoshan Dendrobium Zengye Jiedu Formula mitigates radiation-induced oral mucositis and improves oral immune microenvironment by targeting the EGFR/PI3K/AKT pathway: evidence from network pharmacology, molecular docking, and experimental validation

in Cancer Immunity and Immunotherapy

Chang Liu
Xinru Liu
Jiabao Liu
Hao Zhang
Pengcheng Zhang
Xingxing Huo
Hang Song
Yongfu Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1559400

1,048 views

Review

Published on 10 Mar 2025

A review of common immunotherapy and nano immunotherapy for acute myeloid leukemia

in Cancer Immunity and Immunotherapy

Yaoyao Wang
Xiancong Yang
Yalin Liu
Youjie Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1505247

1,092 views

Original Research

Published on 10 Mar 2025

Hypoxia-associated genes as predictors of outcomes in gastric cancer: a genomic approach

in Cancer Immunity and Immunotherapy

Shuo Yang
Yuhao Jiang
Zhonghua Yang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1553477

1,115 views

Original Research

Published on 07 Mar 2025

Integrative analysis of single-cell and bulk RNA sequencing reveals the oncogenic role of ANXA5 in gastric cancer and its association with drug resistance

in Cancer Immunity and Immunotherapy

Denggang Chen
Peng Zhang
Li Gong
Hailang Wei
Guanghui Yu
Tingting Zhang
Chen Bai

Frontiers in Immunology

doi 10.3389/fimmu.2025.1562395

1,041 views

Original Research

Published on 07 Mar 2025

Immune checkpoint inhibitors and cancer-related cognitive decline: a propensity score matched analysis in active chemotherapy patients

in Cancer Immunity and Immunotherapy

Guangmin Jian
Jiling Zeng
Jun Lu
Weidong Wang
Yongluo Jiang
Tong Huang
Yu Si Niu
Zhoufang Chai
Xin Qi
Nianqi Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1540442

1,145 views

Original Research

Published on 07 Mar 2025

Development of a prognostic model for patients with extensive-stage small cell lung cancer undergoing immunotherapy and chemotherapy

in Cancer Immunity and Immunotherapy

Yunbin Gao
Lixia Zhang
Meng Yan
Zongwen Sun
Haibo Zhao
Lujun Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1561333

642 views

Original Research

Published on 07 Mar 2025

TMED9: a potential therapeutic target and prognostic marker in glioma and its implications across pan-cancer contexts

in Cancer Immunity and Immunotherapy

Benyong Mi
Chaolin Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1558881

678 views

Original Research

Published on 07 Mar 2025

Association of type 2 diabetes, hypertension, and hyperlipidemia with immune-related adverse events in patients undergoing immune checkpoint inhibitors therapy

in Cancer Immunity and Immunotherapy

Ruidan Li
Xiaoli Mu
Zheran Liu
Rendong Huang
Xingchen Peng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1472197

715 views
1 citation

Original Research

Published on 07 Mar 2025

Camrelizumab-based therapies for the treatment of advanced lung cancer: a prospective, open-label, multicenter, observational, real-world study

in Cancer Immunity and Immunotherapy

Dong Zhao
Minghong Bi
Xiaofei Cheng
Shuhong Wang
Huaidong Cheng
Xiaoyang Xia
Huan Chen
Yanbei Zhang
Zhiqiang Hu
Qisheng Cao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1494708

785 views

Review

Published on 07 Mar 2025

Cell-free DNA: plays an essential role in early diagnosis and immunotherapy of pancreatic cancer

in Cancer Immunity and Immunotherapy

Yi Wen
Gengmin Zhao
Chunhua Dai

Frontiers in Immunology

doi 10.3389/fimmu.2025.1546332

777 views

Review

Published on 07 Mar 2025

Exploring effects of gut microbiota on tertiary lymphoid structure formation for tumor immunotherapy

in Cancer Immunity and Immunotherapy

Yuqing Liu
Fan Li
Juanjuan Wang
Rongcun Yang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1518779

1,005 views

Original Research

Published on 07 Mar 2025

Entinostat, a histone deacetylase inhibitor, enhances CAR-NK cell anti-tumor activity by sustaining CAR expression

in Cancer Immunity and Immunotherapy

Dong-Hyeon Jo
Shelby Kaczmarek
Abrar Ul Haq Khan
Jannat Pervin
Diana M. Clark
Suresh Gadde
Lisheng Wang
Scott McComb
Alissa Visram
Seung-Hwan Lee

Frontiers in Immunology

doi 10.3389/fimmu.2025.1533044

1,460 views

Original Research

Published on 06 Mar 2025

Exposing the cellular situation: findings from single cell RNA sequencing in breast cancer

in Cancer Immunity and Immunotherapy

Gaofeng Ni
Xinhan Li
Wenyang Nie
Zhenzhen Zhao
Hua Li
Hongyan Zang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1539074

1,051 views